| INTRODUCTION
The mucous membranes covering the oral cavity, aerodigestive and gastrointestinal tract, and the ducts of all exocrine glands are endowed with powerful mechanical and physicochemical cleansing mechanisms that degrade and repel most foreign matter. 1 The oral cavity represents the beginning of the aerodigestive tract mucous membranes and is one of the most frequently exposed sites to foreign antigens, as it constantly encounters food-borne, water-borne, and air-borne antigens and other environmental insults. 2, 3 Accordingly, immune surveillance in the oral mucosa is highly important for both local and systemic immunity. 3 The oral immune system is part of an extensive and specialised compartmentalised mucosa-associated lymphoid tissue. 4 The oral cavity, pharyngeal and oesophageal mucosae are protected by saliva, which is a biofluid produced mainly by three pairs of major salivary glands-the submandibular, parotid and sublingual glands-along with secretions from many minor submucosal salivary glands. 5 Saliva plays an essential in controlling oral infections and in protecting the teeth from caries by diluting and eliminating sugars and other substances, and via its antimicrobial action. 6 Saliva contains several antimicrobial agents, with the major, and most important, antibody being immunoglobulin (Ig)A. 7 The monomeric fraction of salivary IgA is generally small, and most IgA in the saliva exists as secretory IgA, a dimer. 8 IgA plays a critical role in the defence of mucous membranes against foreign antigens and pathogens, directly neutralises the infectivity of pathogens and their toxins, and contributes to the creation and maintenance of mucosal homoeostasis. 2 A lack of non-specific IgA at the mucosal surface or the inability to produce specific IgA can lead to an increased risk of infection. 9 In particular, many studies have reported associations between the salivary IgA level and the risk of upper respiratory tract infections (URTIs). 10 While some reports found that URTIs were not associated with changes in the salivary IgA level, 11, 12 
| MATERIALS AND METHODS

| Participants
This was an interventional before-after non-randomised controlled study conducted in a population of elderly volunteers residing in a single elderly nursing home. This study was conducted in stages from
October to December 2013. Individuals taking antibiotics or morphine, with gastric fistulae, who disliked yogurt, or who were hospitalised and died during the study period were excluded from the study.
As a result, this study finally enrolled 37 participants (7 men and 5 based on assessment of care requirements) and dementia level (7 levels, scored between 1 and M based on the diagnosis by a medical doctor) were collected from the participants' nursing records. 
| Ethical consideration
| Study protocol
The 
| Experimental design
| Diets
The yogurt used in this study was provided by Meiji Co., Ltd. (Tokyo, Japan). The yogurt was the same as that of the marketing product of the company. The yogurt was prepared using two lactic acid bacterial strains, namely L. bulgaricus OLL1073R-1 and Streptococcus thermophilus OLS3059 (1073R-1 yogurt). 19 These strains were originally isolated from traditional Bulgarian yogurt. 19 The cell counts of L. bulgaricus OLL1073R-1 and S. thermophilus OLS3059 in the yogurts were standardised by Meiji Co., Ltd. Refrigerated yogurts were delivered to the residence of each subject once a week and stored in a refrigerator until intake.
| Saliva collection
The participants' saliva was collected by one dentist or dental hygienist in the morning (9:30 to 10:30 am) before (0 weeks) and after 4, 8 and 12 weeks of yogurt intake. All participants drank one cup of water for oral cavity cleaning 1 hour before saliva collection. We gathered saliva using the saliva-collecting tool Salikids (Sarstedt, Nümbrecht, Germany), which is a sponge roll with a string for prevention of aspiration. The Salikids was placed under the tongues of the participants for 1-5 minutes while sitting. Subsequently, the sponge rolls used to collect the saliva were immediately placed in a plastic tube and cooled on ice. Next, the collected saliva samples were placed in a hybrid high-speed refrigerated centrifuge 6200 (KUBOTA, Tokyo, Japan) and spun at 3,000 g for 5 minutes at 4°C. After measuring the sample volumes, the samples were frozen at −20°C until the time of measurement. The saliva flow rate (mL/min) was determined by dividing the saliva weight (mg) by the sampling time, assuming that the specific density of saliva was 1.00 g/mL. The salivary IgA flow rate (μg/min) was calculated by multiplying the absolute IgA concentration (μg/mL) by the saliva flow rate (mL/min).
| Measurement of IgA concentration
| Statistical analysis
All statistical analyses were performed using JMP version 12 software (SAS Institute Japan, Tokyo, Japan). The results are expressed as the mean and standard error (SE). The statistical analyses for differences in the body weight and body mass index (BMI) before and after 12 weeks of yogurt intake were performed using Welch's t-test.
Statistical analyses for differences in the flow rate of saliva, concentration of IgA in the saliva and IgA flow rate were performed using factorial two-way analysis of variance (ANOVA) including two main effects and one interaction effect. Tukey's multiple comparison was used for post hoc analysis. For all analyses, P -values less than .05
were considered statistically significant.
| RESULTS
| Changes in body weight and body mass index after intake of the study yogurt
There were no significant differences in the body weight or BMI between before and after 12 weeks of yogurt intake (P = .9 and .9, respectively, Welch's t-test; Table 1 ).
T No significant differences in the mean body weight and body mass index were observed between before and after 12 wks of yogurt intake (P = .9 and .9, respectively, Welch's t-test).
| Effects of intake of yogurt fermented with L. bulgaricus OLL1073R-1 and body weight on the IgA flow rate of saliva
There were no effects of the interaction between yogurt intake and body weight on the IgA flow rate of saliva (interaction: P = .8, twoway ANOVA, Figure 1 ). However, when analysed separately, yogurt intake and the body weight of the participants affected the IgA flow rate of saliva (P = .0003 and .03, respectively, two-way ANOVA). The
IgA flow rates of the saliva at 8 and 12 weeks were significantly higher than that at week 0 (P < .05, Figure 1 ).
| Effects of intake of yogurt fermented with L. bulgaricus OLL1073R-1 and body weight on the concentration of IgA in the saliva
There were no effects of the interaction between yogurt intake and body weight on the concentration of IgA in the saliva (interaction: P = .9, two-way ANOVA; Figure 2 ). However, when analysed alone, the intake of yogurt affected the concentration of IgA in the saliva (P < .0001, two-way ANOVA), with the concentrations at 8 and 12 weeks being significantly higher than that at week 0 (P < .05; Figure 2 ).
| Effects of intake of yogurt fermented with L. bulgaricus OLL1073R-1 and body weight on the flow rate of saliva
While the body weight of the participants affected the flow rate of saliva (P = .008, two-way ANOVA), there were no effects of the interaction between yogurt intake and body weight or of yogurt intake alone on the flow rate of saliva (interaction: P = 1.0, yogurt intake:
2, two-way ANOVA; Figure 3 ).
| DISCUSSION
The present study confirmed the effects of yogurt fermented by L. bulgaricus OLL1073R-1 on the secretion of IgA in the saliva of the elderly people residing in a single nursing home. Moreover, we found that intake of yogurt fermented with L. bulgaricus OLL1073R-1, as well as the body weight of the participants, affected the IgA flow rate of saliva ( Figure 1 ).
F I G U R E 1
Effects of intake of yogurt fermented with L. bulgaricus OLL1073R-1 and body weight on the immunoglobulin (Ig)A flow rate of saliva. n = 37. Symbols and vertical bars represent the means and standard errors, respectively. There were no effects of the interaction between yogurt intake and body weight on the IgA flow rate of saliva (P = .7, two-way ANOVA). However, when analysed separately, yogurt intake and body weight both affected the IgA flow rate of saliva (yogurt intake: P = .0003, body weight: P = .03, two-way ANOVA). The IgA flow rates of saliva at 8 and 12 wks were higher than that at week 0 (P < .05, Tukey's multiple comparison). (Body weight < 39.0 kg: n = 3; 39.0-46.9 kg: n = 21; 47.0-54.9 kg: n = 10, ≥55 kg: n = 3) F I G U R E 2 Effects of intake of yogurt fermented with L. bulgaricus OLL1073R-1 and body weight on the concentration of immunoglobulin (Ig)A in the saliva. n = 37. Symbols and vertical bars represent the means and standard errors, respectively. There were no effects of the interaction between yogurt intake and body weight and of body weight alone on the concentration of IgA in the saliva (interaction: P = .9, body weight: P = .8, two-way ANOVA). Conversely, yogurt intake significantly affected the concentration of IgA in the saliva (P < .0001, two-way ANOVA). The concentrations of IgA in the saliva at 8 and 12 wks were higher than that at week 0 (P < 
| Effects of intake of yogurt fermented with L. bulgaricus OLL1073R-1 on the salivary IgA level
Two-way ANOVA showed that the IgA flow rate and concentration of IgA in the saliva were increased by the intake of yogurt fermented with L. bulgaricus OLL1073R-1 (Figures 1 and 2 ). Previous studies have reported some effects on immunity by L. bulgaricus OLL1073R-1.
Consumption of yogurt fermented with L. bulgaricus OLL1073R-1 augmented natural killer cell activity and reduced the risk of catching the common cold in elderly individuals in one previous study. 19 In a mouse model, stimulation of mouse splenocytes by the exopolysaccharides (EPSs) produced by 1073R-1 resulted in significantly increased interferon-gamma production; moreover, orally administered
EPSs were found to augment the natural killer cell activity of the mice. 20 Furthermore, in another animal study, yogurt fermented with 1073R-1 exerted anti-influenza virus effects in mice by its immunopotentiating activity, and the EPSs produced by 1073R-1 were found to be one of the active ingredients. 21 Additionally, oral intake of heatkilled OLL1073R-1 cells also attenuated the secretion of IL-6 from lymph node cells in response to mite antigen and reduced the IL-6 levels in the inflamed tissues, such as the auricles, in mice. 22 However, to our knowledge, this study is the first report showing that salivary
IgA increases after daily intake of yogurt fermented with L. bulgaricus
Salivary IgA is a major effector in mucosal immunity, which prevents submucosal invasion of pathogens. 23 Gleeson et al 24 reported
that reduced levels of salivary IgA are associated with increased frequency of URTIs. As people age, they experience a decline in their immune responses; 24 in turn, as the immune defence activities are relatively weak in such populations, they generally experience more infections. 25 In addition, URTI outbreaks easily spread in nursing homes, 26 and elderly people living in nursing homes are hence especially prone to URTIs. Thus, elevating the IgA flow rate in saliva by intake of yogurt fermented by L. bulgaricus OLL1073R-1 could prove helpful for preventing URTIs in elderly populations. Furthermore, URTI prevention by yogurt intake is a simple method that would be easy to continue for elderly people in nursing homes.
| Effects on mucous immunity by intake of yogurt fermented with L. bulgaricus OLL1073R-1
In the present study, continuous intake of yogurt fermented with adults. The B-cell isotype switch to IgA production is controlled by transforming growth factor (TGF)-β; therefore, it is possible that L. casei strain Shirota induce the production of IgA1 and IgA2 via TGF-β induction. 27 Further, intake of combined probiotics comprising L. casei and Enterococcus faecalis significantly increased the expression level of TGF-β in the piglet jejunum in another study. 28 In the present study, it can be speculated that the intake of yogurt fermented with L. bulgaricus OLL1073R-1 may also activate the gut mucosal immune system and increase the expression levels of cytokines in the gut. IgA production, accompanied by the up-regulation of retinoic acid synthase and TGF-β receptor genes in Peyer's patch cells in mice. 29 In addition, EPS synthesised by intestinal Bifidobacteria from humans increased the levels of SCFAs in vitro. 30 In our previous studies, intake of indigestible carbohydrates was found to increase the IgA concentration and SCFA level in the rat caecal digesta, as well as the rat salivary IgA. 31, 32 Similar to for indigestible carbohydrate intake, the EPSs produced by 1073R-1 might promote fermentation and activate the intestinal tract immune cells. As a result, the concentration of IgA in the saliva might be increased.
Tanida et al 15 reported that both the concentration of IgA in the saliva and the flow rate of saliva significantly decrease with age.
Consequently, the IgA flow rate of saliva is also decreased. Thus, increasing the concentration of IgA in the saliva through oral probiotic administration or yogurt intake would also help increase the IgA flow rate of saliva in elderly persons, in whom the flow rate of saliva is decreased.
| Influence of body weight on the flow rate of saliva and IgA flow rate of saliva
Two-way ANOVA showed that both the flow rate of saliva and the IgA flow rate of saliva were affected by the participants' body weight (Figures 1 and 3) . The IgA flow rate of saliva (μg/min) was calculated by multiplying the absolute IgA concentration (μg/mL) by the flow rate of saliva (mL/min). Therefore, the flow rate of saliva influences the IgA flow rate of saliva. In the present study, when the participants' body weight was low, the flow rate of their saliva tended to be high ( Figure 3 ). Previous studies have reported that the flow rate of saliva in elderly persons is decreased as a result of atrophy and decreased acinar cells in the salivary glands, 33 partly resulting from an increase in adipose tissue of the salivary glands. 34, 35 In the present study, when the body weight was high, the flow rate of saliva tended to be low (Figure 3) , suggesting that the adipose tissue in the salivary glands of participants with a high body weight might be more increased compared to in participants with a low/normal body weight. On the other hand, compared to cases with low/normal body weight, in cases of very low body weight, the flow rate of saliva was also relatively low ( Figure 3 ). In accordance with this finding, it has been reported that the unstimulated flow rate of saliva in elderly people with malnutrition was low. 36 Thus, elderly people with either very low or high body weight are more likely to have decreased flow rate of saliva and IgA flow rate of saliva. Of note, underweight status was found to be a risk factor for higher mortality caused by infections for elderly nursing home populations in one previous study, 37 and obese persons residing in nursing homes have been shown to have higher rates of infectious diseases. 38 Hence, it is possible that the low IgA flow rate of saliva could relate to the higher risk of infectious disease in elderly persons who are under-or overweight.
In our previous research, the IgA flow rate of saliva significantly correlated with the body weight of the study participants. 39 In addition, one-way ANOVA showed that the height of the participants did not affect the flow rate of saliva, concentration of IgA in saliva and IgA flow rate of saliva (P = .9, 1.0, and .7, respectively).
Accordingly, we consider that the body weight of the participants may better reflect the body type of the elderly participants compared to BMI and that analysis of body weight is effective for the study of saliva.
| Considerations
The present study is the first to show that the salivary IgA level is enhanced in elderly persons after continuous intake of yogurt fermented with L. bulgaricus OLL1073R-1. However, there are some limitations that need to be considered when interpreting our results. First, our study did not include a yogurt non-intake group as a control population. Hence, we could not clarify the effect size of intake of yogurt fermented with L. bulgaricus OLL1073R-1 on salivary IgA in elderly persons. Second, we could not rule out the existence of confounding factors, including the effects of seasonal changes, on salivary IgA.
However, Wagner et al 40 reported that no seasonal change was observed in the salivary IgA level in children, and we, therefore, consider that the salivary IgA level in the elderly persons of the present study was not highly affected by seasonal changes. The yogurt used in the present study was the same as that of the marketing product of the company. Thus, we were not able to measure the number of bacteria included in the yogurt. However, the cell counts of L. bulgaricus OLL1073R-1 and S. thermophilus OLS3059 in the yogurts were standardised by Meiji Co., Ltd. 
| CONCLUSION
